Indication
CINCA syndrome
**CINCA syndrome** (chronic infantile neurological cutaneous and articular syndrome), also designated as neonatal-onset multisystem inflammatory disease (NOMID), is a rare, severe autoinflammatory disorder that represents the most debilitating form of cryopyrin-associated periodic syndromes (CAPS). Read more about CINCA syndrome
0 drugs 0 manufacturers
Drugs that treat it
Common CINCA syndrome therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soon**CINCA syndrome** (chronic infantile neurological cutaneous and articular syndrome), also designated as neonatal-onset multisystem inflammatory disease (NOMID), is a rare, severe autoinflammatory disorder that represents the most debilitating form of cryopyrin-associated periodic syndromes (CAPS).
Predominantly presenting in neonates or early infancy, the condition is driven by gain-of-function mutations—either germline or somatic mosaicism—in the *NLRP3* gene, which causes hyperactivation of the NLRP3 inflammasome and uncontrolled overproduction of interleukin-1 beta (IL-1ß).
It is clinically characterized by a classic triad consisting of a migratory, non-pruritic urticaria-like rash; central nervous system manifestations such as chronic aseptic meningitis, sensorineural hearing loss, and papilledema; and progressive, severe arthropathy characterized by abnormal epiphyseal bony overgrowth.
- nih.gov
**CINCA syndrome** (chronic infantile neurological cutaneous and articular syndrome), also designated as neonatal-onset multisystem inflammatory disease (NOMID), is a rare, severe autoinflammatory disorder that represents the most debilitating form of cryopyrin-associated periodic syndromes (CAPS) Predominantly presenting in neonates or early infancy, the condition is driven by gain-of-function mutations—either germline or somatic mosaicism—in the *NLRP3* gene, which causes hyperactivation of th...
- nih.gov
**CINCA syndrome** (chronic infantile neurological cutaneous and articular syndrome), also designated as neonatal-onset multisystem inflammatory disease (NOMID), is a rare, severe autoinflammatory disorder that represents the most debilitating form of cryopyrin-associated periodic syndromes (CAPS) It is clinically characterized by a classic triad consisting of a migratory, non-pruritic urticaria-like rash; central nervous system manifestations such as chronic aseptic meningitis, sensorineural he...
- medlineplus.gov
Predominantly presenting in neonates or early infancy, the condition is driven by gain-of-function mutations—either germline or somatic mosaicism—in the *NLRP3* gene, which causes hyperactivation of the NLRP3 inflammasome and uncontrolled overproduction of interleukin-1 beta (IL-1β) It is clinically characterized by a classic triad consisting of a migratory, non-pruritic urticaria-like rash; central nervous system manifestations such as chronic aseptic meningitis, sensorineural hearing loss, and...
Personalize your experience
Follow CINCA syndrome and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.